Fig. 2: Serum concentrations of the INF-γ (shown as median and interquartile range), IL-10, sBCMA and sCD163 and scatter dot plots with results shown as median and range. | Nature Medicine

Fig. 2: Serum concentrations of the INF-γ (shown as median and interquartile range), IL-10, sBCMA and sCD163 and scatter dot plots with results shown as median and range.

From: Daratumumab monotherapy for refractory lupus nephritis

Fig. 2: Serum concentrations of the INF-γ (shown as median and interquartile range), IL-10, sBCMA and sCD163 and scatter dot plots with results shown as median and range.

*P < 0.05. TO, baseline; T6, 6 months; T12, 12 months. n = 5 biologically independent samples were used for each determination (one per patient/timepoint). The Wilcoxon matched‐pairs signed‐rank test was applied to investigate variations in parameters after treatment. P ≤ 0.05 was considered significant.

Back to article page